Decheng Capital
Biotech Investor · 5 portfolio companies
Portfolio
5
Combined Value
$6.1B
Focus Areas
4
Top Stage
Pre-clinical
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| CG Oncology | $6.1B |
| Phrontline Biopharma | — |
| Firefly Bio | — |
| Excellergy | — |
| AccuraGen | — |